Latest filing published 26 Sept 2023 for Reata Pharmaceuticals INC.
Filing timeline
BuySaleInsider track record
Shamim Ruff: trading record in brief
Shamim Ruff is a declared insider at 2 companies (board member); the most frequent names are Sarepta Therapeutics, Inc. and Reata Pharmaceuticals Inc. Over a trading history stretching from 22 September 2016 to 26 September 2023, the count stands at 33 filings.
Sales make up the whole of the open-market record (7 sales, €2.3M). Other entries cover 10 share grants and 15 option exercises. In 2023 alone, the filings show no purchases and 1 sale.
The newest entry dates from 26 September 2023: a transaction, in Reata Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Shamim Ruff
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,359 sharesClass A common stockSEC:0000899243-23-019539:0
- 1,250 shares@ US$92.2054.6% of flowClass A common stockSEC:0001209191-23-044004:0
- 1,682 shares@ US$93.61Class A common stockSEC:0001209191-23-035879:1
- 454 shares@ US$93.6120.6% of flowClass A common stockSEC:0001209191-23-035879:0
- 1,326 shares@ US$34.76Class A common stockSEC:0001209191-23-018231:1
- 4,215 shares@ US$34.76Class A common stockSEC:0001209191-23-018231:2
- 5,740 shares@ US$83.73Class A common stockSEC:0001209191-23-018231:3
- 199 shares@ US$27.322.7% of flowClass A common stockSEC:0001209191-23-018231:0
- 3,883 shares@ US$34.76Class A common stockSEC:0001209191-22-035423:1
- 1,222 shares@ US$34.7620.6% of flowClass A common stockSEC:0001209191-22-035423:0
- 118 shares@ US$27.321.5% of flowClass A common stockSEC:0001209191-22-001627:0
- 4,432 sharesCommon StockSEC:0001209191-18-033112:0
- 1,305 shares@ US$89.223.8% of flowCommon StockSEC:0001209191-18-033112:1
- 469 shares@ US$13.900.2% of flowCommon StockSEC:0001209191-18-020355:0
- 80 shares@ US$81.220.2% of flowCommon StockSEC:0001209191-18-020355:1
- 2,031 shares@ US$26.241.6% of flowCommon StockSEC:0001209191-18-020355:2
- 656 shares@ US$81.221.6% of flowCommon StockSEC:0001209191-18-020355:3
- 10,000 shares@ US$14.764.8% of flowCommon StockSEC:0001209191-17-059861:0
- 10,000 shares@ US$55.0018.0% of flowCommon StockSEC:0001209191-17-059861:1
- 11,500 shares@ US$14.765.5% of flowCommon StockSEC:0001209191-17-056202:0
- 11,500 shares@ US$50.0018.6% of flowCommon StockSEC:0001209191-17-056202:1
- 2,882 shares@ US$37.883.5% of flowCommon StockSEC:0001209191-17-047903:1
- 8,865 sharesCommon StockSEC:0001209191-17-047903:0
- 6,250 shares@ US$13.712.8% of flowCommon StockSEC:0001209191-17-046037:0
- 6,250 shares@ US$42.008.6% of flowCommon StockSEC:0001209191-17-046037:1
25 of 33 declarations
